AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 158 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,751,000 | +108.5% | 689,447 | +1.1% | 0.01% | +150.0% |
| Q2 2020 | $11,392,000 | +20.1% | 681,788 | +3.7% | 0.00% | 0.0% |
| Q1 2020 | $9,482,000 | -76.5% | 657,657 | -45.5% | 0.00% | -50.0% |
| Q4 2019 | $40,412,000 | +244.7% | 1,207,428 | +115.7% | 0.00% | +33.3% |
| Q3 2019 | $11,723,000 | +3.0% | 559,845 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $11,379,000 | +3.1% | 546,547 | +10.6% | 0.00% | 0.0% |
| Q1 2019 | $11,041,000 | -51.1% | 494,010 | -47.7% | 0.00% | 0.0% |
| Q4 2018 | $22,590,000 | +86.7% | 944,450 | +112.9% | 0.00% | 0.0% |
| Q3 2018 | $12,099,000 | +5.5% | 443,531 | +4.0% | 0.00% | -25.0% |
| Q2 2018 | $11,471,000 | -4.7% | 426,593 | +12.8% | 0.00% | 0.0% |
| Q1 2018 | $12,036,000 | +20.3% | 378,143 | +42.9% | 0.00% | +33.3% |
| Q4 2017 | $10,006,000 | +62.9% | 264,577 | +6.8% | 0.00% | +50.0% |
| Q3 2017 | $6,142,000 | +24.6% | 247,773 | +3.4% | 0.00% | 0.0% |
| Q2 2017 | $4,928,000 | +9.5% | 239,694 | +15.7% | 0.00% | 0.0% |
| Q1 2017 | $4,502,000 | +11.9% | 207,210 | +5.3% | 0.00% | 0.0% |
| Q4 2016 | $4,023,000 | +40.7% | 196,749 | +3.2% | 0.00% | +100.0% |
| Q3 2016 | $2,860,000 | +136.0% | 190,721 | +70.1% | 0.00% | 0.0% |
| Q2 2016 | $1,212,000 | -3.8% | 112,106 | +20.6% | 0.00% | 0.0% |
| Q1 2016 | $1,260,000 | -5.8% | 92,923 | +28.2% | 0.00% | 0.0% |
| Q4 2015 | $1,337,000 | -20.9% | 72,471 | +8.6% | 0.00% | 0.0% |
| Q3 2015 | $1,690,000 | – | 66,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|